Market Overview

Benzinga's Top Initiations

Related AMBI
Ambit Biosciences Slumps: AMBI Falls 13.0% in Session - Tale of the Tape
Ambit's Oncology Drug in Phase III - Analyst Blog
Related CVRR
Is CVR Refining (CVRR) Stock a Solid Choice Right Now? - Tale of the Tape
Stocks Hitting 52-Week Lows

Analysts at Citigroup initiated coverage on shares of Ambit Biosciences (NASDAQ: AMBI) with a “buy” rating. The target price range for Ambit Biosciences is set to $13. Ambit Biosciences' shares closed at $7.79 on Friday.

Goldman Sachs initiated coverage on shares of CVR Refining (NASDAQ: CVRR) with a “neutral” rating. The target price for CVR Refining is set to $37. CVR Refining's shares closed at $30.48 on Friday.

Sterne Agee initiated coverage on shares of Semtech (NASDAQ: SMTC) with a “buy” rating. The target price for Semtech is set to $46. Semtech's stock closed at $35.78 on Friday.

Analysts at Bank of America initiated coverage on shares of Credit Acceptance (NASDAQ: CACC) with a “neutral” rating. The target price for Credit Acceptance is set to $121. Credit Acceptance's shares closed at $113.14 on Friday.

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Most Popular

Related Articles (CACC + AMBI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free